Grand River Aseptic Manufacturing (GRAM), a parenteral drug product contract development and manufacturing organization (CDMO), has completed Phase II of its facility expansion which includes the installation of two new sterile Bausch+Ströbel filling lines. Now, with a total of three separate fill lines, GRAM’s filling capacity reaches over 50 million units per year with space to serve a greater variety of pharma and biotech customers.    GRAM’s state-of-the-art aseptic filling facility is spe...